Remedent (OTCMKTS:REMI) and Item 9 Labs (OTC:INLB) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, valuation, risk, analyst recommendations and dividends. Risk & Volatility Remedent has a beta of -0.56, meaning that its share price is 156% […]
GHENT, Belgium, June 30, 2021 (GLOBE NEWSWIRE) -- Remedent, Inc. (OTC:REMI) ("Remedent" or the "Company") announced today the voluntary filing of a Form 15 ...
GHENT, Belgium, June 30, 2021 (GLOBE NEWSWIRE) -- Remedent, Inc. (OTC Pink: REMI) (" Remedent" or the " Company") announced today the voluntary filing of a Form
GHENT, Belgium, June 30, 2021 (GLOBE NEWSWIRE) -- Remedent, Inc. (OTC Pink: REMI) (“Remedent” or the “Company”) announced today the voluntary filing of a...
GHENT, Belgium, June 01, 2021 (GLOBE NEWSWIRE) -- Remedent, Inc. (OTCBB:REMI.OB), an international company specializing in research, development, and...